Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-18

FDA Approved: FAMOTIDINE — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s original ANDA for famotidine, a generic version of the histamine-2 blocker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)